INNOVATIONS in pharmacy

All Items

• Call to Action: Lead Pharmacy into the Next Decade An Interactive Poster

  Kerry K Fierke, Gardner Lepp, Bridget McGugan, Marta Brooks, Gregory Zumach

  2025-01-14

• Call to Action: Lead Pharmacy into the Next Decade Scholarly Narration

  Gregory Zumach, Kerry K Fierke, Gardner Lepp, Bridget McGugan, Marta Brooks, Anthony Olson, Andrew Bartlett, Nilushi Karunaratne, Betty Exintaris

  2025-01-14

• Call to Action: Lead Pharmacy into the Next Decade Commentary

  Kerry K Fierke, Gardner Lepp, Bridget McGugan, Marta Brooks

  2025-01-14

• Yes, and…?: Reframing pharmacy faculty turnover as interconnectedness

  Sara Thompson

  2024-11-26

• Exposing Pharmacy Residents to Implementation Science

  Anthony Ryan Pinto, Arinze Nkemdirim Okere

  2024-05-31

• Modifying Pharmacy Enrollments by Employment Realities

  Crystal Lloyd, Albert Wertheimer, Thandeka Bissasor, Phat Truong, Nile Khanfar

  2024-05-31

• Development of a Continuous Glucose Monitoring Service by Clinical Pharmacists in a Medically Underserved Population

  Sara Lingow, Kacie Kinnikin, Justinne Guyton

  2024-04-22

• How Pharmacogenomics Informs and Influences the Medication Experience

  Anthony Olson, Jacob Brown

  2024-01-16

• An Overview of the CRoME Lab’s MedSMA℞T Families Intervention for Promoting Opioid Medication Safety among Adolescents and Parents

  Olufunmilola Abraham, Tyler J. McCarthy

  2023-10-31

• Cost-Effectiveness of a Hypothetical Gene Therapy for Alzheimer's Disease: A Markov Simulation Analysis

  Thuy Chinh Kieu, Kevin Look

  2023-09-13

• Pharmacy Practice Innovation: Pharmacist Embeddedness as a Comprehensive Framework for Collaborative Practice

  Jimmy Shangala Mwawaka

  2023-06-28

• Community Forums to Address Vaccine Hesitancy: A Useful Tool for Meeting the Needs of Diverse Communities

  Laura Palombi, Jazmin Belknap, Mary Jo Katras, Grant Anderson

  2023-05-02

• After The QALY: Training for a New Start Paradigm in Health Technology Assessment

  Paul C Langley, Elliott M Sogol

  2023-03-29

• Post-Menopausal Quality of Life Claims: Overlooking the Requirements of Normal Science and Fundamental Measurement in ICER’S Cost-Effectiveness Assessment of Fezolinetant for Moderate to Severe Vasomotor Symptoms

  Paul C Langley

  2023-03-20

• Expunging Board of Pharmacy Disciplinary Actions

  Alex Adams, Timothy P. Frost

  2023-03-06

• Virtual Social Networking Hours: A Vital Personal and Professional Avenue for Connecting Pharmacy Leadership Educators

  Gregory Zumach, Whitney Maxwell, Kerry Fierke

  2023-01-10

• Rasch Measurement and Patient Reported Value Claims: A Primer for Hemophilia

  Paul C Langley

  2022-12-16

• Student Service-Learning Projects: Good Intentions, Questionable Impact

  Saara Z. Nasruddin, Meagen Rosenthal, Vibhuti Arya

  2022-11-23

• The Urgent Need to Intensify Vaccine Development and Manufacturing in Africa: Lessons from Emerging Pandemics

  Melody Okereke, Habeebullah Oladipo, Mercy Aransiola, Faridah Adebowale, Habib Yusuf

  2022-11-09

• Evidentiary Standards for Patient-Centered Core Impact (PC-CIS) Value Claims

  Paul C Langley

  2022-10-25

• The Federal Retail Pharmacy Program (FRPP) Impact on COVID-19 Vaccine Distribution During Pandemic: Effectiveness, Limitations, and Implications

  Gavin Wilson, Taiwo Aremu

  2022-10-18

• A Community Pharmacist’s Guide to Oral COVID-19 Antivirals

  Tyler C. Melton, Brandon K. Hawkins

  2022-10-06

• Formulary Submissions: Value Claims, Protocols and Outcomes Based Contracting in Rare Disease

  Paul Langley

  2022-10-03

• Roles of Community Pharmacists in Cancer Management

  Oluwaseyi Muyiwa Egbewande, Muhsinah Adesewa Abdulwasiu, Rashidat Onyinoyi Yusuf, Aishat Bisoye Durojaye, Zainab Ikeoluwa Ashimiyu-Abdusalam

  2022-09-30

• Concerns with Patient Reported Outcome Measurement and Value Claims for Therapy Response: The Case of Mavacamten and Symptomatic Hypertrophic Cardiomyopathy (SHCM)

  Paul C Langley

  2022-08-03